Liquidia Technologies (LQDA)
(Delayed Data from NSDQ)
$11.23 USD
-0.36 (-3.11%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $11.22 -0.01 (-0.09%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth F Momentum F VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
LQDA 11.23 -0.36(-3.11%)
Will LQDA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for LQDA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for LQDA
Puma Biotech (PBYI) Reports Q2 Loss, Tops Revenue Estimates
IDEAYA Biosciences, Inc. (IDYA) Expected to Beat Earnings Estimates: Should You Buy?
LQDA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Down -11.26% in 4 Weeks, Here's Why You Should You Buy the Dip in Liquidia Technologies (LQDA)
Deciphera Pharmaceuticals, Inc. (DCPH) Reports Q1 Loss, Misses Revenue Estimates
Arvinas, Inc. (ARVN) Reports Q1 Loss, Lags Revenue Estimates
Other News for LQDA
Undercovered Dozen: Burberry, Vinci SA, Lyft, PureCycle +
Liquidia Corporation to Report Second Quarter 2024 Financial Results on August 7, 2024
Liquidia: Attractive Entry Point After Undeserved SCOTUS Appeal Reaction
Liquidia Technologies call volume above normal and directionally bullish
Expert Outlook: Liquidia Through The Eyes Of 5 Analysts